Cas:103637-48-5 1,3-bis(4-benzoyl-3-hydroxyphenoxy)propan-2-yl 2-methylprop-2-enoate manufacturer & supplier

Chemical Name:1,3-bis(4-benzoyl-3-hydroxyphenoxy)propan-2-yl 2-methylprop-2-enoate

CAS.NO:103637-48-5

Synonyms:1,3-BIS(4-BENZOYL-3-HYDROXYPHENOXY)-2-PROPYL METHACRYLATE;1,3-Bis(4-benzoyl-3-hydroxyphenoxy)prop-2-ylmethacrylate;2-Propenoicacid,2-methyl-,2-(4-benzoyl-3-hydroxyphenoxy)-1-[(4-benzoyl-3-hydroxyphenoxy)methyl]ethylester;1,3-Bis(4-benzoyl-3-hydroxyphenoxy)propan-2-yl methacrylate

Molecular Formula:C₃₃H₂₈O₈

Molecular Weight:552.57100

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:N/A

Index of Refraction:1.618

PSA:119.36000

Exact Mass:552.17800

LogP:5.50550

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 1,3-BIS(4-BENZOYL-3-HYDROXYPHENOXY)-2-PROPYL METHACRYLATE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,1,3-Bis(4-benzoyl-3-hydroxyphenoxy)propan-2-yl methacrylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-Propenoicacid,2-methyl-,2-(4-benzoyl-3-hydroxyphenoxy)-1-[(4-benzoyl-3-hydroxyphenoxy)methyl]ethylester Use and application,1,3-BIS(4-BENZOYL-3-HYDROXYPHENOXY)-2-PROPYL METHACRYLATE technical grade,usp/ep/jp grade.

Related News: The Lonza team also contains regulatory specialists with experience working with Chinese regulators throughout the drug development and scale-up process. Approximately 250 employees work at Lonza’s Nansha site; this expansion is expected to create around 70 new positions. (4S,4aS,6aS,11aS,11bS)-9-Methoxy-2,2,4a-trimethyl-2,3,4,4a,5,6,6a,7,10,11,11a,11b-dodecahydro-1H-benzo[a]fluoren-4-ol manufacturers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. N-(2-(1H-indol-3-yl)ethyl)-2,2,2-trichloro-N-(4-((trimethylsilyl)oxy)cyclohex-3-en-1-yl)acetamide suppliers Soliris, first approved for generalized myasthenia gravis (gMG) in 2017, carries a list price of about $470,000 annually. But to ICER, that cost is “well beyond typical thresholds.” 1H-Indazol-3-amine, N-[3-(2,2,6,6-tetrafluoro-4-morpholinyl)propyl]- vendor & factory.